Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial
T. Poynard; P. Marcellin; A. Bissery; R. P. Myers; J. Moussalli; F. Degos; D. Dhumeaux; G. Riachi; J. P. Bronowicki; P. Brissot; C. Buffet; L. Serfaty; S. Naveau; P. Sogni; M. Beaugrand; S. Gayno; D. Larrey; D. Samuel; C. Eugene; S. Pol; P. Bedossa; V. Daurat; P. Chaumet-Riffaud; for the multicenter GER-CYT-RIBANON group
- 作者T. Poynard; P. Marcellin; A. Bissery; R. P. Myers; J. Moussalli; F. Degos; D. Dhumeaux; G. Riachi; J. P. Bronowicki; P. Brissot; C. Buffet; L. Serfaty; S. Naveau; P. Sogni; M. Beaugrand; S. Gayno; D. Larrey; D. Samuel; C. Eugene; S. Pol; P. Bedossa; V. Daurat; P. Chaumet-Riffaud; for the multicenter GER-CYT-RIBANON group
- 卷第10卷
- 期第3期
- 印刷ISSN1352-0504
- 电子ISSN1365-2893
- 文件大小136.72KB
- 发表时间2003
- DOI10.1046/j.1365-2893.2003.00427.x
- 页码197-204